CYP7B1 Gene SPG5A Genetic Test
Test Details
The CYP7B1 gene is associated with a condition called SPG5A, which stands for spastic paraplegia type 5A. SPG5A is a rare neurodegenerative disorder characterized by progressive stiffness and weakness of the legs (spastic paraplegia).
An NGS (next-generation sequencing) genetic test is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the context of SPG5A, an NGS genetic test can identify mutations or variations in the CYP7B1 gene that may be causing the condition. By identifying these genetic changes, NGS testing can help confirm a diagnosis of SPG5A and provide information about the specific genetic variant involved. This information can be useful for genetic counseling, family planning, and potentially guiding treatment options in the future.
It’s important to note that genetic testing should be ordered and interpreted by a qualified healthcare professional, such as a geneticist or genetic counselor, who can provide appropriate guidance and support.
Test Name
CYP7B1 Gene SPG5A Genetic Test
Components
Price: 4400.0 AED
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Method
NGS Technology
Test Type
Neurological Disorders
Doctor
Neurologist
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for CYP7B1 Gene SPG5A NGS Genetic DNA Test
A Genetic Counselling session to draw a pedigree chart of family members affected with CYP7B1 Gene SPG5A
Test Name | CYP7B1 Gene SPG5A Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CYP7B1 Gene SPG5A NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CYP7B1 Gene SPG5A |
Test Details |
The CYP7B1 gene is associated with a condition called SPG5A, which stands for spastic paraplegia type 5A. SPG5A is a rare neurodegenerative disorder characterized by progressive stiffness and weakness of the legs (spastic paraplegia). An NGS (next-generation sequencing) genetic test is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the context of SPG5A, an NGS genetic test can identify mutations or variations in the CYP7B1 gene that may be causing the condition. By identifying these genetic changes, NGS testing can help confirm a diagnosis of SPG5A and provide information about the specific genetic variant involved. This information can be useful for genetic counseling, family planning, and potentially guiding treatment options in the future. It’s important to note that genetic testing should be ordered and interpreted by a qualified healthcare professional, such as a geneticist or genetic counselor, who can provide appropriate guidance and support. |